Home › Funds › Linden Thomas Advisory Services, LLC › CPRX

Linden Thomas Advisory Services, LLC position in CPRX

Catalyst Pharmaceuticals Inc

Linden Thomas Advisory Services, LLC reported holding 176,004 shares of CPRX (Catalyst Pharmaceuticals Inc) in its Q2 2026 13F filing — a position valued at US$5.5M, representing 0.45% of its reported portfolio and ranking #42 among its reported holdings. Linden Thomas Advisory Services, LLC has disclosed CPRX holdings in 11 of the last 11 reported quarters, going back to Q4 2023.

Latest position (Q2 2026)176.00K sh
Reported value held$5.53M
Portfolio Weight0.45%
First reportedQ4 2023
Last changeNew

How Linden Thomas Advisory Services, LLC's CPRX position evolved

Linden Thomas Advisory Services, LLC first disclosed a stake in CPRX in Q4 2023 at 11,077 shares (US$186K). The position peaked in Q2 2026 at 176,004 shares, worth US$5.5M. Across 11 filings, Linden Thomas Advisory Services, LLC increased the stake 9 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 176,004 shares valued at US$5.5M. Notable position changes include a 51% increase in Q1 2024, a 27% increase in Q2 2024, a 262% increase in Q2 2025.

Quarter by quarter

QuarterSharesValueChange
Q4 2023 11.08K $186.20K New
Q1 2024 16.74K $266.88K Add
Q2 2024 21.33K $330.34K Add
Q3 2024 26.91K $534.91K Add
Q4 2024 32.64K $681.18K Add
Q1 2025 35.23K $854.40K Add
Q2 2025 127.43K $2.77M Add
Q3 2025 135.58K $2.67M Add
Q4 2025 139.90K $3.27M Add
Q1 2026 163.59K $4.05M Add
Q2 2026 176.00K $5.53M New

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CPRX and 13F data

CPRX (Catalyst Pharmaceuticals Inc) is a company whose sector is not yet classified in our data. 43 other funds we track also report a position in CPRX — the largest reported positions include BlackRock Inc (US$602.2M), Vanguard Group (US$196.8M), AMERICAN CENTURY COMPANIES INC (US$174.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CPRX

All CPRX fund holders →